Stay updated with breaking news from Ancer Prostate . Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Their link with metastases, and thus with aggressive tumors, gives them an advantage over other biomarkers in the early identification of invasive tumors for therapeutic intervention.
More than half of patients with advanced cancer would not want a treatment that delays time to progression without any improvement in overall survival.
MRI-guided stereotactic body radiotherapy not only provides more precise delivery of prostate radiation but also pays off in fewer genitourinary and bowel side effects, new research shows.
Using early-response biomarkers in patients treated with lutetium-177 PSMA-617 can help personalize dosing intervals and potentially improve outcomes.
The newly approved device from Urotronic relieves enlarged prostate symptoms without requiring burns or implants.